ACHIEVE LIFE SCIENCES INC
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page hereto)
Power of Attorney
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John Bencich and Richard Stewart, jointly and severally, as such person’s attorneys-in-fact, each with the power of substitution, for such person in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By: /s/ JOHN BENCICH | Chief Executive Officer and Director (Principal Executive Officer and Financial Officer) | Date: March 28, 2024 |
|---|---|---|
| John Bencich | ||
| By: /s/ JERRY WAN | Senior Director of Accounting Operations (Principal Accounting Officer) | Date: March 28, 2024 |
| Jerry Wan | ||
| By: /s/ RICHARD STEWART | Executive Chairman and Director | Date: March 28, 2024 |
| Richard Stewart | ||
| By: /s/ CINDY JACOBS | President, Chief Medical Officer and Director | Date: March 28, 2024 |
| Cindy Jacobs | ||
| By: /s/ BRIDGET MARTELL | Director | Date: March 28, 2024 |
| Bridget Martell | ||
| By: /s/ VAUGHN HIMES | Director | Date: March 28, 2024 |
| Vaughn Himes | ||
| By: /s/ STUART DUTY | Director | Date: March 28, 2024 |
| Stuart Duty | ||
| By: /s/ THOMAS KING | Director | Date: March 28, 2024 |
| Thomas King | ||
| By: /s/ THOMAS SELLIG | Director | Date: March 28, 2024 |
|---|---|---|
| Thomas Sellig | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.